Article metrics

Original research
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

 

Online download statistics by month:

Online download statistics by month: June 2021 to October 2021

AbstractFullPdf
Jun 2021873882235
Jul 202129029066
Aug 202119219255
Sep 202119018954
Oct 202117517556
Total17201728466